 
 
											Prescient Therapeutics Ltd
ASX:PTX ISIN:AU000000PTX3
												
                                                 Prescient Therapeutics Limited is a clinical-stage oncology company. The Company's principal activities include in-licensing of intellectual property; the preparation for and conduct of clinical trials relating to the Company's products; business development associated with the promotion of its technologies and products, and business development associated with developing collaborative, partnership relationships and corporate transactions. 
 
 
											
										 
 
											Nouvelles
											###
											
										145,686 COMPANY PROFILE VIEWS
- This Page Viewed: (7 derniers jours: 34) (Last 30 Days: 122) (Since Published: 11248)













